A growing body of evidence demonstrates the benefits of machine perfusion with LifePort for improving outcomes following renal transplant.

• Machine preservation of kidneys with LifePort significantly reduces the risk of delayed graft function (DGF) and significantly improves
  1-year graft outcomes.
• LifePort significantly reduces the risk of DGF in donation after cardiac death (DCD) kidneys.
• By reducing DGF and increasing graft survival, machine preservation of kidneys with LifePort lowers the costs associated with kidney transplantation for both standard criteria donor (SCD) organs and expanded criteria donor (ECD) organs.
• Machine preservation of kidneys with LifePort leads to improved clinical outcomes compared with cold storage, and is more cost-effective for transplants involving SCD and ECD kidneys.